Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment, Journal of Managed Care & Specialty Pharmacy, March 2016, Academy of Managed Care Pharmacy,
DOI: 10.18553/jmcp.2016.22.3.293.
You can read the full text:
Contributors
The following have contributed to this page
